December 7, 2017
Pelagia, the parent company of Epax Norway AS, is pleased to announce that Bjørn Refsum is entering the position of Managing Director of Epax Norway AS as of January 1, 2018.
Bjørn Refsum, who is a Norwegian citizen, has through almost 20 years in the Omega-3 business gained excellent experience from both the Epax® Omega-3 business and as a consultant to the Peruvian fishing company Copeinca. He holds a master degree in Chemical Engineering, and has broad experience from the Pharmaceutical industry. Bjørn Refsum joins Epax from Nordic Pharma Inc., a subsidiary of US based Nordic Naturals, where he held the position as Managing Director.
Epax is a leading global brand of concentrated marine-based Omega-3 fatty acids for dietary supplement and pharmaceutical preparations. The Epax Omega-3 product line complement Pelagia’s existing product offerings and add to the strategy of increasing the portfolio of value added products.
Part of Pelagia’s strategy is to create exciting synergies between the resources in Epax and the core strength of Pelagia. It is expected that parts of Pelagia’s fantastic North Atlantic fish oil product offerings can be further refined and gain direct Human consumption market access through future and existing processes developed by Epax. Bjørn Refsum share this vision and the team at Pelagia and Epax look forward to his comeback in 2018.
About Epax Norway AS:
Epax Norway AS is a world-leading, B2B provider of marine Omega-3 concentrates committed to ingredients of unmatched purity and quality. Using only high-quality, sustainable and traceable raw materials, Epax delivers safe and ultra-pure condition-specific Omega-3 formulas that have been scientifically validated in numerous clinical studies over the past two decades. The ongoing commitment to purity, quality and innovation guarantees that both customers and health-minded consumers get the highest quality of safe Omega-3 EPA/DHA ingredients on the market. Epax Norway AS is part of Pelagia AS.
About Pelagia AS:
Pelagia AS is a leading producer of pelagic fish products for human consumption, and an important supplier of essential ingredients in all kinds of fish- and animal feed; protein concentrate, fishmeal, and fish oil. The company operates 26 factories in Norway, United Kingdom, Ireland, and Denmark. Twenty-three of the factories are 100% owned, while three are partly owned associates, and the operation is divided into two divisions; Food (consumption) and Feed (protein concentrate, fishmeal and fish oil). The Food division exports close to 100% of its products, while Feed’s products are mainly sold in the domestic market as essential ingredients in fish- and animal feed production. Austevoll Seafood ASA and Kvefi AS own Pelagia in a 50/50 share split. Egil Magne Haugstad is the company’s CEO.
You May Also Like
Advancing gender equity in the nutraceutical industrySep 25, 2023
CRN petition to FTC: RCTs aren’t required to substantiate ‘health-benefit’ claimsSep 22, 2023
Collagen peptide ingredient solutions for seniors’ changing needs – infographicSep 19, 2023
Radicle Insights—Covid Eris and dietary supplements: separating fact from fictionSep 21, 2023